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Abstract: The aim of this retrospective study was to evaluate implant survival, marginal bone loss
and peri-implant complications in 326 short and ultra-short implants. Implants were placed in the
maxillary and mandibular posterior regions of 140 patients with (PP) and without (NPP) a history
of periodontal disease. Clinical and radiographic examinations were performed at 3-year recall
appointments. The 8.0, 6.0 and 5.0 mm-length implants placed in PP and NPP were respectively 43.75%
and 38.46%, 35.10% and 34.19%, 21.15% and 27.35%; 325 implants (one early failure) were rehabilitated
with single crowns in 139 patients. Overall implant survival after 3 years of follow-up was 97.55%,
98.08% and 96.61% for PP and NPP (p = 0.46). Crestal bone level variations were not statistically
different among PP and NPP; 15.41% of implants presented signs of mucositis, 14.71% and 16.67% in
PP and NPP (p = 0.64). Setting the threshold for bone loss at 2 mm after 36 months, peri-implantitis
prevalence was 2.2%, 1.96% and 2.63% in PP and NPP (p = 0.7). Overall implant success was 82.39%,
83.33% and 80.7% for PP and NPP (p = 0.55). Short-term outcomes suggest that short and ultra-short
locking-taper implants can successfully be restored with single crowns in the posterior jaws both in
PP and NPP.
Keywords: bone loss; mucositis; peri-implantitis; periodontal disease; short; single crown; success;
survival; ultra-short
1. Introduction
The placement of standard-length implants in conjunction with vertical bone augmentation
and major reconstructive procedures usually implies longer treatment times and increased risk of
post-operative complications [1]. As implant dimensions have considerably decreased in length and
diameter during the last decades [2,3], these drawbacks can be easily avoided by choosing minimally
invasive alternative treatments [4], which provide various advantages both for clinicians and patients.
On that note, the use of short (length≥ 6 mm and≤8 mm) and ultra-short (length≤ 5 mm) [5] implants in
the rehabilitation of extreme maxillary and mandibular atrophies is reported to be as effective as the use
of longer implants [6–8] in terms of implant survival and bone level stability at medium-term follow-up.
On the other hand, recent RCTs (randomized controlled trials) [9] assessed lower cumulative survival
rates for short and ultra-short implants, also considering long-term follow-up (at least 5 years) [10].
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Furthermore, it is reported [11] that short narrow-diameter implants supporting single-crown can be
associated with greater marginal bone loss compared to standard implants.
While outcomes such as implants survival and marginal bone loss were widely evaluated in many
studies [12–15], the influence of biological complications on implants failure was less investigated [16,17].
As implant success directly regards the onset of mucositis and peri-implantitis [18–21], their prevention
and management [22] are essential in long-term maintenance of healthy hard and soft peri-implant
tissues. Peri-implant mucositis [23] is characterized by bleeding on gentle probing; erythema, swelling,
and/or suppuration may also be present. An increase in probing depth is often observed in the presence
of peri-implant mucositis, due to swelling or decrease in probing resistance. It is not possible to define a
range of probing depths compatible with peri-implant health, as it can also exist around implants with
reduced bone support [23]. There is strong evidence from animal and human experimental studies [23]
that plaque is the etiological factor for peri-implant mucositis. Thus, peri-mucositis associated with
poor plaque control [24] can be reversed with efficient measures aimed at eliminating the deposits and
preventing the development of a subsequent peri-implantitis.
Peri-implantitis [23] is a plaque-associated pathological condition occurring in tissues around
dental implants, characterized by inflammation in the peri-implant mucosa and subsequent progressive
loss of supporting bone. Peri-implantitis sites exhibit clinical signs of inflammation, bleeding on
probing, and/or suppuration, increased probing depths and/or recession of the mucosal margin,
in addition to radiographic bone loss (greater than 2 mm [25,26]).
In addition to implant-related and prosthesis-related variables considered for the assessment of
implants survival and success, there is an emerging matter about the importance of patient-related
factors, such as systemic diseases, smoking [26–29] and history of periodontal disease. The latter
may be considered a preponderant risk factor for the occurrence of peri-implantitis [30,31]. However,
the evidence [26,32,33] concerning clinical and radiographic outcomes of short and ultra-short implants
placed in patients with treated periodontitis is still scarce, in addition to a lack of homogeneous
follow-up terms in the current studies.
The aim of this 3-year retrospective study was to evaluate implant survival, marginal bone loss
and implant success in 326 short and ultra-short implants restored with single crowns. The implants
were placed in the maxillary and mandibular, edentulous posterior regions of patients with history of
periodontal disease (PP), and without history of periodontal disease (NPP).
2. Materials and Methods
2.1. Study Design and Inclusion Criteria
In total, 326 implants (191 in the posterior mandible and 135 in the posterior maxilla) placed in
140 patients were included in the study. Patients included in the study had been referred between
February 2007 and June 2015 for edentulism (tooth loss caused by trauma, caries or periodontal disease)
in the posterior areas of maxilla and mandible at the Dental and Maxillo-Facial Surgery Clinic at the
University of Verona (Italy). A 3-year follow-up retrospective study [34,35] was conducted between
June and October 2018. The study was approved by the University of Verona Institutional Review
Board (Prot. 34934, TISSUESMAXMAND, 30/05/18). The study was conducted (see Appendix A)
according to guidelines previously described [34,35].
Patients enrolled for the study matched the following inclusion criteria [34,35]: aged between
18 and 90 years; single-tooth replacement of at least one 8.0, 6.0 or 5.0 mm locking-taper implant
supporting a single crown; had no previous consent for bone augmentation procedures; had a history
of treated chronic periodontal diseases or never being affected by any forms of periodontal disease;
compliance to the regular maintenance program (professional oral hygiene sessions every four months).
Exclusion criteria comprehended several conditions (see Appendix A), as previously described [34,35].
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2.2. Surgical Protocol
The implant system used in this study presented specific characteristics [34,35]. Moreover,
pre-surgical evaluation was conducted as previously described [34,35] (see Appendix A).
All surgical treatments were carried out by a single clinician. A full-thickness flap was performed,
and a high-speed 2.0 mm-diameter pilot drill (with a cutting edge at the apical portion and drilling at
1100 rpm) with external saline irrigation was used to perforate the cortical plate. Final pilot drilling
length was determined by measuring residual bone height and adding at least 1.0 mm to the selected
implant length to allow for a sub-crestal implant placement. Latch reamers presenting a 0.5 mm
progressive increase in diameter were used at 50 rpm, without external irrigation, to widen the
osteotomy until the final implant diameter was reached. The selected implant was manually inserted
into the osteotomy, a healing plug was placed in the implant well, and autogenous bone collected
during the slow speed preparation of the osteotomy was used to fill the gap between the implant and
the bony walls. The incisions were closed by single polyglycolic acid sutures (Vycril, ACE Surgical
Supply Co., Brockton, MA, USA). A post-operative periapical radiograph was taken, and the patient
received post-operative instructions, antibiotic and analgesic prescriptions [34,35].
2.3. Prosthetic Protocol and Follow-Up Evaluation
Prosthetic loading and follow-up assessment (see Appendix A) were conducted as previously
described [34,35]. The post-surgery evaluation and the follow-up evaluation were respectively
performed by other two operators, both different from the clinician who performed the surgical phase.
By way of illustration, Figures 1–4 report some radiographic cases.
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Figure 1. Single implants placed in 3.6 and 3.7 sites (4.5 × 6 m and 6 × 5 mm) of a
male patient with history of periodontal disease: (a) pre-operative radiograph before implants
placement; (b) radiograph obtained at implants placement; (c) radiograph obtained at time of loading;
(d) radiograph obtained at 3-year follow-up.
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Figure 3. Single implant placed in 2.6 site (4.5 × 8 mm) of a male patient without history of periodontal 
disease: (a) pre-operative radiograph before implant placement; (b) radiograph obtained at implant 
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Figure 3. Single implant placed in 2.6 site (4.5 × 8 mm) of a male patient without history of periodontal
disease: (a) pre-operative radiograph before implant placement; (b) radiograph obtained at implant
placement; (c) radiograph obtained at time of loading; (d) radiograph obtained at 3-year follow-up.
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Figure 4. Single implant placed in 1.5 site (4.5 × 6 mm) of a male patient with history of periodontal
disease: (a) pre-operative radiograph before implant placement; (b) radiograph obtained at implant
placement; (c) radiograph obtained at time of loading; (d) radiograph obtained at 3-year follow-up.
2.4. Study Variables and Outcomes
Implant lengths considered in the study ere 8.0, 6.0 and 5.0 mm; implant diameters were 3, 3.5,
4.0, 4.5, 5.0, 6.0, and 6.5 mm. Covariates included were: sex, age, smoking history, history of periodontal
disease, ASA (American Society of Anesthesiologists) physical status classification, number of oral
hygiene sessions per year, use of interproximal oral hygiene devices, arch, tooth site, prosthetic material,
crown-to-implant ratio (CIR) [34,35]. Patients with a history of periodontitis (PP) were characterized by
previously assessed chronic forms of periodontal disease, corresponding to stage I, II or III, and grade
A or B, according to the latest updates on classification of periodontal and peri-implant diseases [24].
PP were subjects following a regular maintenance program on a reduced periodontium, to ensure
gingival health at the time of implant placement. On the other hand, periodontally healthy patients
(NPP) were subjects never affected by any forms of periodontal diseases.
Study outcomes were implant survival, marginal bone loss and implant success after 3 years of follow-up.
Implant survival and marginal bone loss (see Appendix A) were assessed as previously described [34,35].
Peri-implant soft tissues were assessed using a periodontal probe (Florida Probe; Florida Probes
Company, Gainesville, FL, USA), applying a force of mild intensity (0.25 N). F r each implant site,
four par meters were assessed. The Modified Ble ding Index (mBI) and the Modified Plaque Index
(mPLI), s reported in the lit ratur by Mombe li [36], were used to record the appropriate values
for the mesial, central, and distal on the bucca and lingual/palatal sides of each implant. Similarly,
the peri-implant probing depths (PPD) were performed on the s me six sit s. The amount of keratinized
tissue (KT) was assessed by measuring the distance between the zenith of the buccal gingival margin
and the mucogingival line [37].
Biological complications after loading were also assessed at the 3-year recall appointment.
According to the latest updates [23], we defined mucositis as at least one soft-tissue peri-implant surface
with positive BOP (bleeding on probing) or pus on probing, PPD ≥ 4 mm and no radiographically
detectable bone loss, as it should be noted that visual signs of inflammation can vary and
that peri-implant mucositis can exist around implants with variable levels of bone support [24].
We diagnosed peri-implantitis when an implant had simultaneously one surface with positive BOP
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or pus on probing, increasing PPD compared to previous examinations, and the presence of bone
loss beyond crestal bone level changes resulting from initial bone remodeling. In the absence of the
previous examination data, diagnosis of peri-implantitis was otherwise based on the combination of
presence of positive BOP or pus on probing, PPD ≥ 5 mm [38] and a radiographically detectable bone
loss greater than 2 mm [23,24] when compared with the loading measurements.
Implant success was defined according to the following criteria [39,40]: absence of persistent pain,
dysesthesia or paraesthesia in the implant area; absence of peri-implant infection with or without
suppuration; absence of perceptible mobility of the implant; absence of persistent peri-implant bone
resorption >1.5 mm during the first year of loading and >0.2 mm/year during the following years.
Once excluded, the failed implants, implant success thus considered implants not presenting signs of
mucositis or peri-implantitis.
2.5. Statistical Analysis
For data collection, a database including all patients evaluated in the study was created with
Microsoft Excel. All data analysis was carried out using Stata v.13.0 for Macintosh (StataCorp,




A total of 140 patients (64 men and 76 women) received at least one 8.0, 6.0 or 5.0 mm-length
single-crown dental implant. 78.57% of the patients were non-smokers, 50.71% ASA status I, 55% with
history of periodontal disease. All patients were compliant with the maintenance program, following a
mean of 2.89 ± 1.19 oral professional hygiene sessions in a year and 74.28% of them used interproximal
oral hygiene devices daily. Mean age at placement was 54.14 ± 10.73 (range 28–80) years.
Of implants placed, 136 (41.72%) were 8 mm-length, 114 (34.97%) were 6 mm-length and 76 (23.31%)
were 5 mm-length; 191 (58.59%) and 135 (41.41%) implants were respectively positioned in the posterior
mandible and maxilla; 208 (63.8%) and 118 (36.2%) implants were respectively positioned in PP
and NPP. One implant in the posterior upper maxilla failed before loading, thus 325 implants in
139 patients (63 men and 76 women) were finally rehabilitated with single crowns. The mean CIR
was 1.92 ± 0.52 (range 0.91–4.1) and 51.69% of the implants presented a CIR ≥2. CIR in PP and NPP
was, respectively, 1.94 ± 0.55 (range 0.91–4.1) and 1.88 ± 0.45 (range 1.09–3.1), with no statistically
significant differences among groups (p = 0.58). The loaded implants distribution, analyzed according
to PP and NPP, is presented in Table 1.
Table 1. Overall loaded implants: PP/NPP-groups distribution according to study variables.
PP = patients with history of periodontal disease; NPP = patients without history of periodontal
disease; ASA = American Society of Anesthesiologists physical status classification. Age at follow-up
and oral professional hygiene/year are presented as mean ± standard deviation; for all other variables,
values are presented as n (%); NS = not statistically significant; d.f. = degrees of freedom.
Variable NPP PP Test Statistic d.f. p Value
Sex
male 53 (45.30) 89 (42.79)
χ2 = 0.19 1 NS (p = 0.66)female 64 (54.70) 119 (57.21)
Age at follow-up 55.41 ± 10.56 60.56 ± 9.95 F = 19.18 1/325 <0.001
Smoking history
no 87 (74.36) 172 (82.69)
χ2 = 3.21 1 NS (p = 0.07)yes 30 (25.64) 36 (17.31)
ASA status
I 65 (55.56) 80 (38.46)
χ2 = 9.03 1 0.01II 52 (44.44) 128 (61.54)
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Table 1. Cont.
Variable NPP PP Test Statistic d.f. p Value
Oral professional hygiene/year 2.88 ± 1.34 2.89 ± 1.11 F = 14.31 1/325 NS (p = 0.92)
Use of interproximal oral hygiene devices
no 30 (25.64) 51 (24.52)
χ2 = 0.05 1 NS (p = 0.82)yes 87 (74.36) 157 (75.48)
Implant length
5 mm 32 (27.35) 44 (21.15)
χ2 = 1.74 2 NS (p = 0.41)6 mm 40 (34.19) 73 (35.10)
8 mm 45 (38.46) 91 (43.75)
Implant tooth site
premolar 46 (39.32) 98 (47.12)
χ2 = 1.84 1 NS (p = 0.17)molar 71 (60.68) 110 (52.88)
Arch
posterior mandible 68 (58.12) 123 (59.13)
χ2 = 0.03 1 NS (p = 0.85)posterior maxilla 49 (41.88) 85 (40.87)
Implant diameter
3 mm 1 (0.85) 0 (0.00)
χ2 = 5.75 6 NS (p = 0.44)
3.5 mm 6 (5.13) 7 (3.37)
4 mm 28 (23.93) 61 (29.33)
4.5 mm 39 (33.33) 76 (36.54)
5 mm 36 (30.77) 55 (26.44)
6 mm 6 (5.13) 9 (4.33)
6.5 mm 1 (0.85) 0 (0.00)
Prosthetic material
resin 18 (15.38) 35 (16.83)
χ2 = 0.11 1 NS (p = 0.73)porcelain 99 (84.62) 173 (83.17)
Crown-to-implant ratio (CIR)
<2 68 (58.12) 89 (42.79)
χ2 = 7.75 2 0.022 < CIR < 2.99 48 (41.03) 113 (54.33)
>2.99 1 (0.85) 6 (2.88)
3.2. Implant Survival and Marginal Bone Loss
One early failure was assessed, and seven implants were lost and removed after functional
loading in seven different patients. The overall implant survival at the 36-month follow-up was 97.55%
(318/326). Failures features are recorded in Table 2.
Table 2. Failures features.
Site 45 46 24 47 16 34 44 17
Diameter 6 4.5 4 5 5 4.5 5 5
Length 5 8 5 6 6 8 8 6
Sex male male female female male male male male
Smoking history no no no no yes yes no no
ASA status I I I II II II II I
Oral professional hygiene/year 3 4 4 4 3 2 4 4
History of periodontal disease yes no no no yes yes yes no
Crown-to-implant ratio 2.76 1.38 2.25 2.17 2.68 1.69 1.62 /
Failure late late late late late late late early
No association was found between survival and failure groups, and any of the covariates
considered (Table 3).
The implant survival according to length-groups was 97.79% for 8 mm-length implants, 97.37% for
6 mm-length implants, 97.37% for 5 mm-length implants, respectively. According to arch-groups,
97.38% of the implants in the posterior mandible and 97.78% in the posterior maxilla survived.
In regard to history of periodontal disease, 208 implants placed in patients with a history of chronic
periodontitis presented a survival of 98.08%, while 118 implants placed in patients who had no
history of periodontal disease, but lost their teeth for other reasons, presented a survival of 96.61%.
No statistically significant differences after 3 years of follow-up were found between length-groups
(p = 0.97), arch-groups (p = 0.56) or PP/NPP-groups (p = 0.46).
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Table 3. Analysis of implant survival according to study covariates included. For all variables,





n (%) n (%)
Sex
male 137 (95.80) 6 (4.20)
χ2 = 3.22 1 NS (p = 0.14)female 181 (98.91) 2 (1.09)
Smoking history
no 254 (97.69) 6 (2.31)
χ2 = 0.11 1 NS (p = 0.66)yes 64 (96.97) 2 (3.03)
ASA status
I 142 (97.26) 4 (2.74) χ2 = 4.41 1 NS (p = 0.11)
II 176 (97.78) 4 (2.22)
History of periodontal disease
no 114 (96.61) 4 (3.39)
χ2 = 0.67 1 NS (p = 0.46)yes 204 (98.08) 4 (1.92)
Implant tooth site
premolar 140 (97.22) 4 (2.78)
χ2 = 0.11 1 NS (p = 0.73)molar 178 (97.80) 4 (2.20)
Arch
posterior mandible 186 (97.38) 5 (2.62)
χ2 = 0.05 1 NS (p = 0.56)posterior maxilla 132 (97.78) 3 (2.22)
Implant diameter
3 mm 1 (100.00) 0 (0.00)
3.5 mm 13 (100.00) 0 (0.00)
4 mm 88 (98.88) 1 (1.12) χ2 = 3.77 6 NS (p = 0.41)
4.5 mm 113 (98.26) 2 (1.74)
5 mm 88 (95.65) 4 (4.35)
6 mm 14 (93.33) 1 (6.67)
6.5 mm 1 (100.00) 0 (0.00)
Implant length
8 mm 133 (97.79) 3 (2.21)
χ2 = 0.06 2 NS (p = 0.97)6 mm 111 (97.37) 3 (2.63)
5 mm 74 (97.37) 2 (2.63)
Prosthetic material
resin 53 (100) 0 (0.00)
χ2 = 1.39 1 NS (p = 0.60)porcelain 265 (97.43) 7 (2.57)
Crown-to-implant ratio
<2 154 (98.09) 3 (1.91)
χ2 = 0.33 2 NS (p = 0.76)2–2.99 157 (97.52) 4 (2.48)
>2.99 7 (100.00) 0 (0.00)
∆CBL (average bone loss) and ∆F-BIC (average apical shift of the “first bone-to-implant contact
point” position), compared by one-way non-parametric analysis of variance (ANOVA) with each
covariate as between-patients factor, were not statistically different among length-groups, arch-groups
or PP/NPP-groups after 3 years of follow-up. Crestal bone level variations are reported in Table 4.
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Table 4. Overall CBL/F-BIC (crestal bone level/first bone-to-implant contact) distributions and analysis
of ∆CBL/∆F-BIC according to PP/NPP-groups, length-groups and arch-groups. CBL/F-BIC and
its variations are presented as median [iqr, interquartile range]; NS = not statistically significant;
d.f. = degrees of freedom.
Variable Overall
History of
Periodontal Disease Implant Length Arch




Loading time 1.97 2.17 1.93 1.82 1.87 2.20 2.10 1.88
[median (iqr)] (1.64) (1.53) (1.63) (1.40) (1.83) (1.71) (1.62) (1.63)
Follow-up time 1.57 1.57 1.58 1.42 1.55 1.78 1.59 1.55
[median (iqr)] (1.8) (1.67) (1.86) (1.75) (1.97) (1.86) (1.78) (1.90)
∆CBL 0.36 0.41 0.34 0.32 0.36 0.36 0.33 0.45
[median (iqr)] (1.03) (1.08) (0.95) (1.05) (0.96) (1.11) (1.00) (0.99)
test statistic
d.f. Z = 0.38 χ2 = 0.23 Z = −0.82
p value 2
NS (p = 0.69) NS (p = 0.89) NS (p = 0.40)
F-BIC
Loading time 0.22 0.01 0.28 0.37 0.18 0.18 0.23 0.21
[median (iqr)] (0.66) (0.54) (0.70) (0.71) (0.62) (0.65) (0.68) (0.66)
Follow-up time 0.40 0.44 0.38 0.53 0.39 0.33 0.43 0.38
[median (iqr)] (0.84) (0.85) (0.81) (0.73) (0.85) (0.72) (0.89) (0.74)
∆F-BIC 0.05 0.14 0.01 0.19 0.09 0.01 0.09 0.01
[median (iqr)] (0.56) (0.46) (0.57) (0.56) (0.63) (0.41) (0.46) (0.60)
test statistic
d.f. Z = 1.73 χ2 = 2.77 Z = 1.67
p value 2
NS (p = 0.08) NS (p = 0.24) NS (p = 0.09)
3.3. Soft Tissues’ Conditions and Implant Success
No statistically significant differences in soft tissues’ conditions (PPD, mBI, mPLI and KT), at 3-year
recall appointment, were found between length-groups, arch-groups or PP/NPP-groups (Table 5),
except for KT values between length-groups (p < 0.001).
Table 5. Overall soft tissues indices (Modified Bleeding Index (mBI), Modified Plaque Index (mPLI),
peri-implant probing depths (PPD) [mm], keratinized tissue (KT) [mm]) according to PP/NPP-groups,
length-groups and arch-groups. mBI, mPLI, PPD and KT are presented as mean ± standard deviation;




Test Statistic d.f. p Value[mean ± sd]
Overall 0.9 ± 0.8
History of periodontal disease
no 0.9 ± 0.83 Z = −0.08 NS (p = 0.93)
yes 0.9 ± 0.79
Arch
posterior mandible 0.91 ± 0.82 Z = 0.16 NS (p = 0.87)
posterior maxilla 0.88 ± 0.78
Implant length
8 mm 0.86 ± 0.75
6 mm 0.92 ± 0.79 χ2 = 0.20 2 NS (p = 0.90)
5 mm 0.94 ± 0.92




Test Statistic d.f. p Value[mean ± sd]
Overall 0.52 ± 0.73
History of periodontal disease
no 0.56 ± 0.79 Z = 0.23 NS (p = 0.81)
yes 0.5 ± 0.69
Arch
posterior mandible 0.5 ± 0.72 Z = −0.77 NS (p = 0.43)
posterior maxilla 0.55 ± 0.74
Implant length
8 mm 0.48 ± 0.67
6 mm 0.49 ± 0.72 χ2 = 1.89 2 NS (p = 0.38)
5 mm 0.64 ± 0.82
Variable
PPD
Test Statistic d.f. p Value[mean ± sd]
Overall 3.29 ± 1.28
History of periodontal disease
no 3.35 ± 1.4 Z = 0.18 NS (p = 0.85)
yes 3.26 ± 1.2
Arch
posterior mandible 3.29 ± 1.41 Z = −0.68 NS (p = 0.49)
posterior maxilla 3.29 ± 1.07
Implant length
8 mm 3.33 ± 1.35
6 mm 3.23 ± 1.08 χ2 = 0.12 2 NS (p = 0.93)
5 mm 3.32 ± 1.42
Variable
KT
Test Statistic d.f. p Value[mean ± sd]
Overall 2.47 ± 1.69
History of periodontal disease
no 2.49 ± 1.79 Z = 0.19 NS (p = 0.84)
yes 2.45 ± 1.63
Arch
posterior mandible 2.41 ± 1.69 Z = −0.70 NS (p = 0.48)
posterior maxilla 2.54 ± 1.68
Implant length
8 mm 3.2 ± 1.63
6 mm 1.8 ± 1.41 χ2 = 44.52 2 <0.001
5 mm 2.14 ± 1.68
Among 318 survived implants at the 3-year follow-up, 49 (15.41%) exhibited peri-mucositis
and 7 (2.2%) presented peri-implantitis, for a total of 56 implants (17.61%) presenting biological
complications. A statistically greater prevalence of peri-mucositis (p < 0.01) was found in the posterior
mandible compared to the posterior maxilla (Tables 6 and 7).
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Table 6. Prevalence of peri-mucositis according to PP/NPP-groups, length-groups and arch-groups.




χ2 d.f. p Valuen (%) n (%)
History of periodontal disease
no 95 (83.33) 19 (16.67)
0.21 1 NS (p = 0.64)yes 174 (85.29) 30 (14.71)
Arch
posterior mandible 148 (79.57) 38 (20.43)
8.66 1 <0.01posterior maxilla 121 (91.67) 11 (8.33)
Implant length
8 mm 118 (88.72) 15 (11.28)
3.98 2 NS (p = 0.13)6 mm 93 (83.78) 18 (16.22)
5 mm 58 (78.38) 16 (21.62)
Table 7. Prevalence of peri-implantitis according to PP/NPP-groups, length-groups and arch-groups.




χ2 d.f. p Valuen (%) n (%)
History of periodontal disease
no 111 (97.37) 3 (2.63)
0.15 1 NS (p = 0.70)yes 200 (98.04) 4 (1.96)
Arch
posterior mandible 182 (97.85) 4 (2.15)
0.005 1 NS (p = 0.61)posterior maxilla 129 (97.73) 3 (2.27)
Implant length
8 mm 131 (98.50) 2 (1.50)
1.56 2 NS (p = 0.49)6 mm 109 (98.20) 2 (1.80)
5 mm 71 (95.95) 3 (4.05)
The overall implant success at 36-month follow-up (Table 8) was 82.39% (262/318): 87.22% for
8.0 mm-length implants, 81.98% for 6.0 mm-length implants, 74.32% for 5.0 mm-length implants
respectively (p = 0.06); 77.42% for posterior mandible and 89.39% for posterior maxilla (p < 0.01);
83.33% for PP and 80.7% for NPP (p = 0.55).
Table 8. Implant success according to PP/NPP-groups, length-groups and arch-groups. For all variables,
values are presented as n (%); NS = not statistically significant; d.f. = degrees of freedom.
Variable
Success No Success
χ2 d.f. p Valuen (%) n (%)
History of periodontal disease
no 92 (80.70) 22 (19.30)
0.34 1 NS (p = 0.55)yes 170 (83.33) 34 (16.67)
Arch
posterior mandible 144 (77.42) 42 (22.58)
7.63 1 <0.01posterior maxilla 118 (89.39) 14 (10.61)
Implant length
8 mm 116 (87.22) 17 (12.78)
5.46 2 NS (p = 0.06)6 mm 91 (81.98) 20 (18.02)
5 mm 55 (74.32) 19 (25.68)
No associations were found between peri-mucositis or peri-implantitis and any of the
covariates considered, except for the number of oral professional hygiene/year (p = 0.01) related to
peri-mucositis insurgence.
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4. Discussion
Peri-implantitis is defined as inflammation of the peri-implant mucosa, plaque association and
non-reversible, radiographically detectable bone loss that exceeds normal physiological remodelling [42].
This condition, in the absence of treatment, seems to progress in a non-linear and accelerating
pattern [19,43,44]. A strong similarity between the bacterial composition of sites with periodontitis
and sites with peri-implantitis has been observed [45–47]. This could be considered a crucial point
in endorsing the implant placement in patients without a history of periodontal disease, in order to
avoid the possibility of serious peri-implant complications. Furthermore, residual pockets at the end
of active periodontal therapy represent a significant risk for the development of peri-implant bone
loss in patients susceptible to periodontitis [48], even if the patient is compliant to an established
maintenance protocol.
Current reported prevalence of peri-implant diseases is not unequivocally determined
in literature [23,26,49,50], because of multiple discrepancies regarding different definition,
implant-related characteristics, prosthetic protocols and bone loss threshold indicative of destructive
process. A systematic review based on an average follow-up of 3 years [20] reported an implant-based
prevalence of peri-implant mucositis and peri-implantitis of 29.48% and 9.25% respectively.
Nevertheless, recent studies showed that implants placed in NPP demonstrate fewer failures,
and consequent higher percentages of implant survival, compared to those placed in PP. Karoussis et al.
stated [51] that implants in patients with history of periodontitis usually encounter less survival
(90.5%) compared to implants in patients with no past history of periodontitis (96.5%) after a long-term
follow-up. Hardt et al. [52] considered 346 implants placed in the posterior maxillary areas with a
follow-up of 5 years: the survival was 96.7% and 92% for NPP and PP respectively. Roccuzzo et al. [53]
found a 10-year survival rate of 96.6%, 92.8% and 90% for 61, 95 and 90 implants placed respectively in
periodontally healthy patients, patients with a history of moderate periodontitis and patients with a
history of severe periodontitis.
Concerning the increased risk for developing peri-implantitis due to the susceptibility to
periodontitis, stated by many authors [26,50,54–57], Changi et el. [50], in a 3.5-year study
on 6129 implants, demonstrated that radiographic evidence of periodontitis is one of the principal
risk-factor statistically associated (odds ratio (OR) = 3.6) with peri-implantitis. Renvert et al. [57]
found a OR even equal to 4.5 assessing the likelihood of association between peri-implantitis and history
of periodontitis. Moreover, insurgence of peri-implantitis seem to be higher in PP: Karoussis et al.
considered [51] 112 ITI dental implants, comparing 21 implants placed in PP and 91 implants in NPP,
both following regular supportive therapy for 10 years, and found that incidence of peri-implantitis in
NPP (5.8%) was lower compared to PP (28.6%). In a 3- to 5-year cross-sectional study, Arunyanak et al.
found [58] that prevalence of peri-implantitis was significantly higher in PP (25% in 72 patients)
compared to NPP (10.9% in 128 patients).
On the other hand, investigations involving short implants (length ≥6 mm and ≤8 mm)
and considering a history of periodontal disease as a variable with potential correlation with failure
and biological complications, are still scarce in literature. Hasanoglu et al., [33] in a multicenter
long-term retrospective study on 460 short implants (4 to 9 mm in length) placed both in posterior
and anterior regions of maxilla and mandible of 299 patients, found an overall implant survival of
95.86% and a prevalence of peri-implantitis of 10% after a follow-up of up to 9 years, with 73.91%
of failures caused by peri-implantitis; in this study, 70.85% of implants were placed in patients
without a history of periodontal disease. Zhang et al. [59], in a study on 214 implants, whose length
was less than 8 mm in 25 implants, assessed implant-related variables (e.g., length, diameter and
position) and periodontal-related variables (e.g., soft tissue indexes and marginal bone-level alterations),
identifying residual pockets and posterior region as predictors for peri-implantitis. Akram et al. [32],
in a 3-year follow-up study, compared the clinical and radiographic conditions between teeth of healthy
patients (11) and short implants placed in patients treated for aggressive periodontitis (48); soft tissues
parameters of PI, BOP, PD and CAL were recorded, finding a significantly greater attachment loss in
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implants compared to teeth. Correia et al. [60], in a retrospective study on 689 implants in 202 patients,
found an overall implant survival of 95.8% for NPP (214 implants) and 93.1% for PP (475 implants),
after 3 years of follow up, with no statistically significant differences between groups; moreover,
short implants showed a survival of 97.3% and 93% for NPP (74 implants) and PP (157 implants)
respectively, with no statistically significant differences between groups.
Similarly, in this 3-year retrospective study, a history of periodontitis seemed not to be correlated
to implant failure, as no statistically significant differences in implant survival were found between PP
and NPP.
Excessive bone loss after loading can influence both implant survival and success: our results
showed that bone level stability was preserved after 3 years, without significant differences between
implant placed in PP and NPP. It is also worth noting that the implant system examined in the
study presents a screw-less locking-taper implant-abutment connection, which increases mechanical
stability with no micromovements or micro-gaps at the implant-abutment interface and provides
minimal bone resorption [61]. Moreover, the convergent crest module in short and ultra-short
implants seems to have an important influence on marginal bone loss. Referring to biomechanical
models which compare different crest modules, the quantity of bone present around the neck of
the implant is fundamental for the distribution of the occlusal forces [62,63]. The transmission of
vertical, horizontal and rotational forces on F-BIC is thus more favorable and homogeneous in implants
with convergent crest module compared to implants with divergent crest module with the same
diameter. Furthermore, the sloping shoulder guarantees a platform switching at implant level with
bone growth over the neck, assuring successful long-term functioning together with the specific plateau
root-form design [62].
The literature supports a general agreement that implants can be successfully placed in periodontal
patients if proper supportive protocols of maintenance are applied before and after loading [64,65],
in order to prevent peri-implant mucositis and peri-implantitis. Some authors [66] claimed that
current definitions of peri-implant health and diseases are still greatly debated and controversial,
as healthy implant mucosa may bleed upon probing, thus leading to high number of false-positives.
Nevertheless, an increase of probing pocket depth values over time is not necessarily associated with
loss of supporting bone around dental implants. It is also suggested that bleeding on probing should
be used as a diagnostic tool and as an indicator for treatment in association with probing pocket
depth of at least ≥4 mm, the presence of abundant plaque deposits, and radiographic detection of
bone loss [66]. Furthermore, the evidence is equivocal regarding the effects of keratinized mucosa
(which was statistically different between length-groups in our study) on the long-term health of the
peri-implant tissue, such as patient comfort and ease of plaque removal [23].
In the present study, where patients adhered to a strictly observed protocol of TPS,
low inflammatory indexes were generally assessed, with a positively significant correlation with the
number of oral hygiene interventions administered per year. Finally, only 15.41% of the implants
presented signs of mucositis, with no statistically significant differences between PP and NPP.
Similar results were found in a study by Zorzano et al. [67], where 786 implants were placed in
239 periodontally compromised patients, who regularly received supportive periodontal therapy;
after a mean follow-up of 63 months, 12.8% of the implants were affected by peri-mucositis and 9.8%
by peri-implantitis.
However, the present study, being retrospective, presents some critical issues. The medium
sample size, the relatively short evaluation (3 years of follow-up) and a non-homogeneous distribution
among implant length-groups, arch-groups and PP/NPP-groups are the product of its retrospective
nature. The single-center setting, involving a university dental clinic, could also have introduced an
important bias, suggesting that our results cannot be generalized.
Another issue that could represent a critical limit for the study is that most of the implants were
placed in patients characterized by a history of periodontal disease: nonetheless, after 3 years of loading,
the main strengths of our study rests on a positive assessment of the proportion of surviving implants
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and bone level stability when placing short and ultra-short single-crown locking-taper implants both
in PP and NPP. Furthermore, all patients enrolled in the study showed a positive compliance to the
maintenance program.
Prospective long-term (5-year follow-up or longer) studies are necessary for a better evaluation of
larger homogenous samples, and a more balanced distribution between patients with and without a
history of periodontal disease is desirable.
5. Conclusions
Short-term outcomes suggest that short and ultra-short locking-taper implants can be successfully
placed and restored with single crowns in the atrophic posterior jaws both in PP and NPP. By contrast
with several studies in the literature, our outcomes showed that a history of periodontal disease does
not seem to negatively influence peri-implant conditions. Suitable maintenance procedures before
implant placement and during the follow-up time, together with adequate compliance of the patients
in daily homecare, mainly contributed to our stable results, both for PP and NPP. Further investigations
with longer follow-up are, of course, necessary to validate these conclusions.
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Appendix A.
Appendix A.1. Study Design and Inclusion Criteria
The nature and aim of the study, together with the anonymity in the scientific use of data,
were clearly presented in a written informed consent form, and signed by every patient. All procedures
accorded with Helsinki Declaration and good clinical practice guidelines for research on human
beings [34,35].
Exclusion criteria for the study were [34,35]: presence of active infection at an implant site;
ASA status III (according to the American Society of Anesthesiologists classification), that is severe
systemic diseases or substantive functional limitations which contraindicated implant surgery (such as
drug or alcohol abuse, uncontrolled diabetes mellitus, immunosuppression or immunodepression,
severe autoimmune diseases, treatment or past treatment with intravenous amino-bisphosphonates for
metastatic bone diseases, radiotherapy to head or neck within two years prior to treatment, history of
malignancy or chemotherapy within the previous year, treatment with oral amino-bisphosphonates
for more than three years, morbid obesity, active hepatitis, severe renal disease, severe cardiovascular
conditions, recent history of myocardial infarction (MI) or transient ischemic attack (TIA)); ASA status
IV, V, and VI; untreated periodontitis; poor oral hygiene and motivation; current pregnancy or lactation;
heavy smoking (more than 25 cigarettes per day); severe clenching or bruxism.
Appendix A.2. Surgical Protocol
The locking-taper (Morse taper or Morse cone) dental implant system (Bicon Dental Implants,
Boston, MA, USA, designed in 1985) used in this study presents an implant interface connection to its
restoration, which is impervious to bacterial penetration or infiltration [68]. The implant system also
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includes a convergent crest module, platform switching, plateau root-form design, and an Integra CP
surface (hydroxyapatite treated and acid-etched) [34,35].
A complete clinical and radiographic evaluation (dental and periodontal status; panoramic and
periapical radiograph, cone beam computed tomography) and basic periodontal treatment was
performed before implant placement. A pre-operative medication consisting of 2 g of Augmentin
(875 mg amoxicillin plus 125 mg clavulanic acid), or 1 g of Klacid (Clarithromycin 500 mg) if allergic
to penicillin, was given one hour before surgery. All surgical procedures were performed under
local anaesthesia, using only Articain 4% with adrenaline 1:100,000 (Citocartin) or Articain 4% with
adrenaline 1:100,000 (Citocartin) associated with oral sedation (Halcion 0.25 mg) [34,35].
Appendix A.3. Prosthetic Protocol and Follow-Up Evaluation
After 4 to 6 months the implants were surgically uncovered, and the healing abutments
placed, readapting the mucosal flaps around them. After three weeks of soft tissue healing,
impressions were taken using a polyether material (3M ESPE Impregum Impression Material).
Definitive single-crown porcelain or composite restorations were delivered within two weeks.
The choice for restorative materials (porcelain or composite) was based on patients’ preference,
guided by personal economic resources in most of the cases. The technique used for the composite
restorations was the Integrated Abutment Crown (IAC), in which the abutment and the crown material
are extra-orally chemo-mechanically bonded; therefore, there is no need for cement, and the implant
and implant-abutment are connected with a screwless locking-taper connection [34,35,69].
Recall appointments were established to manage prosthetic complications as needed.
A maintenance program was designed in order to provide patients a professional oral hygiene
session every four months. Clinical and radiographic examinations were performed during the
follow-up 3 years from loading time [34,35].
Appendix A.4. Study Variables and Outcomes
In regard to implant survival, failure was considered as the need for implant removal either before
loading (due to no osseointegration) or after loading (due to excessive bone loss). Implant survival
was thus considered as the implant’s state of being in function at the three-year follow-up evaluation,
that is, symptom-free, without mobility, radiolucency, or bone loss so severe as to warrant
implant removal [12,34,35,70,71].
A descriptive analysis of crestal bone level (CBL, average bone level around implants at mesial and
distal sides, in mm) and first bone-to-implant contact (F-BIC, in mm) [72–74] along with their variations
∆CBL (average bone loss) and ∆F-BIC (average apical shift of the “first bone-to-implant contact
point” position), was conducted between loading time and the 3-year follow-up time, according to
covariates. Peri-implant bone levels were measured through digitally scanned intraoral radiographs,
performed with a paralleling technique [75], using Rinn centering devices (Rinn XCP Posterior Aiming
Ring-Yellow, Dentsply, Elgin, IL, USA), immediately after implant placement, at healing abutment
placement, at prosthetic loading, and after 3 years of loading. The implant–abutment interface (IAI)
was taken as a reference for measurements. CBL was measured on mesial and distal sides as the linear
distance between the IAI and the highest point of the interproximal bone crest parallel to the lateral
sides of the implant body: a positive value was given when the crest was located coronally to the
IAI and a negative value when the crest was located apically to the IAI. For every implant, at each
examination interval, an average mesial-distal value was calculated. F-BIC was defined as the first
most coronal bone-to-implant relationship visible at the first line of contact, on both mesial and distal
sides; if F-BIC matches with IAI, the measurement was 0; if it is located apically, the measurement was
a positive value [34,35]. As described in the literature [76], implants were divided into two groups
on the basis of presenting a CIR less than or greater than two. The crown height was measured on
the radiograph immediately after the prosthetic loading, from the most occlusal point to the IAI.
Anatomical crown-to-implant ratio (in which the fulcrum is positioned at the interface between the
Int. J. Environ. Res. Public Health 2020, 17, 9354 16 of 20
implant shoulder and the crown-abutment complex) was calculated by dividing the digital length of
the crown by the digital length of the implant [34,35].
Measurements were assessed with the aid of a software program (Rasband, W.S., ImageJ,
U. S. National Institutes of Health, Bethesda, Maryland, USA) which uses a measuring tool in
conjunction with a magnification tool. To correct the distortion of the radiographic image, the apparent
size of each implant (measured directly on the radiograph) was compared with the actual length to
determine, with adequate precision, the amount of any changes of the crestal bone around each implant.
The measurements were made to the nearest 0.01 mm. One dentist who was not involved in the
treatment of the patients completed all the measurements on periapical radiographs; the observation
intervals of radiographs were masked to the examiner. Before the start of the study, this investigator
was calibrated for intra-examiner adequate levels of accuracy and reproducibility in recording the
radiographic parameters. Three radiographs were enrolled for this purpose: duplicate measurements
for CBL, F-BIC and CIR were collected with an interval of 24 h between the first and second recording.
The intra-class correlation coefficients, used as a measure of intra-examiner reproducibility, had to be
greater than 0.8 [34,35].
Appendix A.5. Statistical Analysis
The normality assumptions for continuous data were assessed by using the Shapiro–Wilk test;
mean and standard deviation were reported for normally distributed data, median and interquartile
range (iqr) otherwise. For categorical data, absolute frequencies, percentages and 95% confidence
intervals were reported. The association between categorical variables was tested with χ2 test; if any of
the expected values was less than 5, a Fisher’s exact test was performed. The comparison between the
means of continuous variables in two different times was performed by using paired Student’s “t”
test or Wilcoxon matched-pairs signed-rank test. The comparison between the means of two different
groups was performed using unpaired Student’s “t”, or Wilcoxon rank-sum test. The comparison of the
means among more than two groups was undertaken using one-way analysis of variance (ANOVA),
or the Kruskal–Wallis equality-of-populations rank test. Significance level was set at 0.05 [34,35].
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